BioVersys and GSK to Unveil New Alpibectir Tuberculosis Data at The Union World Conference on Lung Health

BioVersys and GSK will present new Phase 2 data on alpibectir combined with ethionamide for drug-sensitive pulmonary tuberculosis at The Union World C...